Schnaper H W, Aune T M
J Clin Invest. 1987 Jan;79(1):257-64. doi: 10.1172/JCI112792.
Soluble immune response suppressor (SIRS), a lymphokine that suppresses antibody production and delayed type hypersensitivity in vivo, has been detected in urine and serum from certain patients with nephrotic syndrome. In the present paper, the relationship between SIRS production and nephrotic syndrome is further characterized. A striking correlation was found between detection of SIRS and the presence of steroid-responsive nephrotic syndrome (SRNS). A potential mechanism of SIRS production in SRNS patients was identified, in that lymphocytes from patients produced SIRS without requiring activation by exogenous agents, and incubation of normal lymphocytes with serum from patients activated the cells to secrete SIRS in culture. Although SIRS disappears rapidly from urine or serum after initiation of corticosteroid therapy, hydrocortisone (10(-6)-10(-7) M) did not block secretion of SIRS by activated suppressor cells. It did, however, inhibit in vitro activation of lymphocytes to produce SIRS by concanavalin A, interferon, or SRNS patient serum. The association of suppressor cell activation with SRNS and the sensitivity of both to steroids suggest that the pathogeneses of albuminuria and SIRS production are related.
可溶性免疫反应抑制因子(SIRS)是一种在体内抑制抗体产生和迟发型超敏反应的淋巴因子,已在某些肾病综合征患者的尿液和血清中检测到。在本文中,进一步阐述了SIRS产生与肾病综合征之间的关系。发现SIRS的检测与类固醇反应性肾病综合征(SRNS)的存在之间存在显著相关性。确定了SRNS患者中SIRS产生的潜在机制,即患者的淋巴细胞无需外源性因子激活即可产生SIRS,而正常淋巴细胞与患者血清一起孵育可激活细胞在培养物中分泌SIRS。尽管在开始皮质类固醇治疗后SIRS会迅速从尿液或血清中消失,但氢化可的松(10^(-6)-10^(-7) M)并不能阻止活化的抑制细胞分泌SIRS。然而,它确实抑制了伴刀豆球蛋白A、干扰素或SRNS患者血清在体外激活淋巴细胞产生SIRS。抑制细胞活化与SRNS的关联以及两者对类固醇的敏感性表明蛋白尿和SIRS产生的发病机制是相关的。